ECSP993167A - COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES - Google Patents

COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES

Info

Publication number
ECSP993167A
ECSP993167A ECSP993167A ECSP993167A EC SP993167 A ECSP993167 A EC SP993167A EC SP993167 A ECSP993167 A EC SP993167A EC SP993167 A ECSP993167 A EC SP993167A
Authority
EC
Ecuador
Prior art keywords
composition
allergic diseases
treating allergic
effective amount
neuroquinine
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Neng Yang Shih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993167 priority Critical patent/ECSP993167A/en
Publication of ECSP993167A publication Critical patent/ECSP993167A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica útil para el tratamiento de la rinitiis alérgica, el asma y trastornos relacionados. En una realización, la composición comprende, en combinación, una cantidad terapéuticamente efectiva de al menos un antagonista de neuroquinina, una cantidad efectiva de al menos un inhibidor de 5-lipoxigenasa.The present invention relates to a pharmaceutical composition useful for the treatment of allergic rhinitis, asthma, and related disorders. In one embodiment, the composition comprises, in combination, a therapeutically effective amount of at least one neuroquinine antagonist, an effective amount of at least one 5-lipoxygenase inhibitor.

ECSP993167 1999-10-06 1999-10-06 COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES ECSP993167A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993167 ECSP993167A (en) 1999-10-06 1999-10-06 COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993167 ECSP993167A (en) 1999-10-06 1999-10-06 COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES

Publications (1)

Publication Number Publication Date
ECSP993167A true ECSP993167A (en) 2000-05-25

Family

ID=42044155

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993167 ECSP993167A (en) 1999-10-06 1999-10-06 COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES

Country Status (1)

Country Link
EC (1) ECSP993167A (en)

Similar Documents

Publication Publication Date Title
SE9803710D0 (en) Use of certain drugs for treating nerve root injury
BRPI0407993B8 (en) p38 inhibitor compounds and pharmaceutical compositions comprising the same
DE60332604D1 (en) AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITOR
PL373903A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
WO2002038142A3 (en) Serotonergic compositions and methods for treatment of mild cognitive impairment
NO20060328L (en) Combination of mGluR2 antagonist and ACHE inhibitor for the treatment of acute and / or chronic neurological disorders
DE602004012418D1 (en) PIPERAZINE DERIVATIVES AND METHOD OF USE
PA8583501A1 (en) PIRROLIDONE DERIVATIVES AS MAOB INHIBITORS
WO2007087151A3 (en) Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction
WO2004005279A3 (en) Substituted anthranilic amide derivatives and methods of use
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
BRPI0411864A (en) combination of src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
PA8571901A1 (en) NEW PHARMACEUTICAL COMPOSITION
AR020740A1 (en) COMPOSITION AND METHOD TO TREAT ALLERGIC DISEASES
AR020741A1 (en) COMPOSITION AND METHOD TO TREAT ALLERGIC DISEASES
BG106748A (en) Method and compositions for treating pulmonary diseases
BR9909641A (en) Processes for treating or preventing asthma or its symptoms, dermatitis, allergic rhinitis and inflammation in a human and a condition responsive to leukotriene inhibition, and pharmaceutical composition
ECSP993168A (en) COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES
BRPI0416202A (en) phosphodiesterase inhibitor formulations v
AU2003259198A8 (en) Method and composition for treating and preventing influenza infection and symptoms thereof
BRPI0419229A (en) thiophenopyrimidinone derivatives substituted as 17betahydroxysteroid dehydrogenase inhibitors, use and pharmaceutical composition
NO20053247D0 (en) Use of levocetirizine in the treatment of persistent allergic rhinitis.
BR0314364A (en) Use of iv pde inhibitors to treat angiogenesis
WO2000054770A8 (en) Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
ATE526954T1 (en) ATOMOXETINE FOR THE TREATMENT OF ALLERGIC RHINITIS AND ASTHMA